Jiangxi Boya Bio-Pharmaceutical Co Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangxi Boya Bio-Pharmaceutical Co Ltd with three other
companies in this sector in China:
Zhenxing Biopharmaceutical & Chemical Inc
sales of 500.27 million Chinese Renmimbi [US$73.15 million]
of which 99%
was Pharmaceutical Sales),
Zhongyuan Union Cell & Gene Engineering Corp Ltd
(706.86 million Chinese Renmimbi [US$103.36 million]
of which 60%
was Scientific research service), and
Pulike Biological Engineering Inc
(478.01 million Chinese Renmimbi [US$69.89 million]
of which 77%
was Animal Biological Products).
During the year ended December of 2015, sales at
Jiangxi Boya Bio-Pharmaceutical Co Ltd were 543.10 million Chinese Renmimbi (US$79.41 million).
increase of 24.1%
versus 2014, when the company's sales were 437.77 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Jiangxi Boya Bio-Pharmaceutical Co Ltd
(and since 2010, sales have increased a total of 283%).